blood in stool tirzepatide and mucus stool: what patients should know Mounjaro (tirzepatide) side effects &

Westchester County Weight Loss Specialist Transform your weight loss journey with Dr

The dual GIP/GLP-1 receptor agonist tirzepatide has already been approved and other dual receptor agonists are expected soon

Our preclinical findings highlight that promoting healthier food options may contribute to the weight-loss success of therapeutic Tirzepatide use for patients

A large retrospective study in JAMA Neurology (2025) identified more than 44,000 IIH patients and then compared matched cohorts

Hair Loss Reports Linked to Ozempic and Similar Drugs Hair loss has previously been reported as a possible side effect of GLP-1 receptor agonists, particularly medications containing semaglutide or tirzepatide

GLP-1 helps do this in several ways